Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Rhodia Analgesics Are Sold To Novacap

by Michael McCoy
April 25, 2011 | A version of this story appeared in Volume 89, Issue 17

Rhodia is selling its business in the bulk analgesics aspirin and acetaminophen to Novacap, a French firm that was created in 2003 out of several former Rhodia businesses. The deal, which also includes the intermediates salicylic acid and methyl salicylate, involves plants in France, China, Thailand, and Brazil that collectively employ about 390 people. Rhodia is in the process of being acquired by Solvay in a $4.8 billion deal.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.